BactiQuant A/S (9JX) Stock Statistics & Valuation Metrics

BactiQuant A/S has a market cap or net worth of €9.70M. The enterprise value is €92.18M.

BactiQuant A/S has 29,371,857 shares outstanding. The number of shares has decreased by -2.65% in one year.

BactiQuant A/S’s return on equity (ROE) is -19.91 and return on invested capital (ROIC) is -110.16%.

The current PE Ratio of BactiQuant A/S is -5.81. BactiQuant A/S’s PEG ratio is ―.

In the last 12 months, BactiQuant A/S had revenue of 7.18M and earned -13.72M in profits. Earnings per share was -0.52.

In the last 12 months, operating cash flow was -10.01M and capital expenditures -623.17K, giving a free cash flow of -10.64M billion.

BactiQuant A/S pays an annual dividend of ―, resulting in a dividend yield of ―

BactiQuant A/S upcoming earnings date is ―, ―.

BactiQuant A/S as a current ratio of 1.56, with Debt / Equity ratio of 1565.19%

In the past 12 months, BactiQuant A/S has paid 0.00 in taxes.

BactiQuant A/S EV to EBITDA ratio is -7.66, with an EV/FCF ratio of -6.92.

BactiQuant A/S has €906.58K in cash and marketable securities with kr9.35M in debt, giving a net cash position of €8.44M billion.

Gross margin is -161.42%, with operating margin of -176.21%, and net profit margin of -191.25%.

The average price target for BactiQuant A/S is ―, which is 11.43% higher than the current price. The consensus rating is ―